End-of-day quote
Shenzhen S.E.
23:00:00 19/05/2024 BST
5-day change
1st Jan Change
9.72
CNY
-0.82%
+0.93%
-4.80%
Edan Instruments, Inc.'s Equity Buyback announced on February 9, 2021, has expired with 2,555,300 shares, representing 0.44% for CNY 35.01 million.
The company expired its plan on February 7, 2022.
Edan Instruments, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
04-25
CI
Edan Instruments, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
03-28
CI
Edan Instruments, Inc. Focus on Medical Technology Advancement Shines At Medica 2023
11-14
CI
Edan Instruments, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023
24/10/23
CI
Edan Instruments, Inc. Strengthens its APAC Business Landscape with Thailand Office Launch
01/09/23
CI
Edan Instruments, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023
22/08/23
CI
Edan Instruments, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
26/04/23
CI
Edan Instruments, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
28/03/23
CI
Edan Instruments, Inc. Establishes Peru Office, Edan Diagnostics Peru S.A.C. in Lima
13/03/23
CI
Edan Instruments, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022
25/10/22
CI
Edan Instruments, Inc. Showcases Its First Molecular Diagnostics Analysis System, ClariLight CL30, at Medlab Asia & Asia Health 2022
19/10/22
CI
Edan Instruments, Inc. Reports Earnings Results for the Half Year Ended June 30, 2022
23/08/22
CI
Edan Instruments, Inc. Launches i20
26/07/22
CI
Edan Instruments, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
26/04/22
CI
Edan Instruments, Inc. Announces Appointment of Zheng Quanlu as Independent Director and Zhou Yirong as Non-Employee Supervisors
21/04/22
CI
Edan Instruments, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
23/03/22
CI
Tranche Update on Edan Instruments, Inc.'s Equity Buyback Plan announced on February 9, 2021.
08/02/22
CI
Edan Instruments, Inc.'s Equity Buyback announced on February 9, 2021, has expired with 2,555,300 shares, representing 0.44% for CNY 35.01 million.
06/02/22
CI
Tranche Update on Edan Instruments, Inc.'s Equity Buyback Plan announced on February 9, 2021.
04/01/22
CI
Edan Instruments, Inc. Announces Clinical Data Shows the Efficacy of In-Phase and Quadrature Demodulation in Electronic Fetal Heart Rate Monitoring During Labor
18/11/21
CI
Edan Instruments, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2021
26/10/21
CI
Tranche Update on Edan Instruments, Inc.'s Equity Buyback Plan announced on February 9, 2021.
11/10/21
CI
Edan Instruments, Inc.'s Equity Buyback announced on October 14, 2020, has expired.
27/09/21
CI
Edan Instruments, Inc.(XSEC:300206) added to S&P Global BMI Index
20/09/21
CI
Edan Instruments, Inc. Reports Earnings Results for the Half Year Ended June 30, 2021
23/08/21
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Edan Instruments, Inc. is a China-based company principally engaged in the research, development, manufacture, sales of medical electronic equipment products and in-vitro diagnostic products, as well as the provision of related services. The Company provides maternity product series, including doppler fetal heart beat monitors, ultrasonic doppler fetal heart beat monitors, fetal/maternal monitors and maternity integrated diagnostic monitoring systems; electrocardiograph series, including digital twelve-channel electrocardiographs, digital six-channel electrocardiographs, electrocardiographic workstations, single-channel electrocardiographs and multi-channel electrocardiographs; monitoring product series, including portable multi-variable monitors, central monitoring systems and oximeters, as well as ultrasonic image product series, including digital ultrasonic diagnostic systems and others. The Company is also involved in the spare parts sale and in vitro diagnostics products business.
More about the company
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1